Avodart dutasteride regulatory update

FDA approved an sNDA from GlaxoSmithKline for Avodart dutasteride to treat symptomatic benign prostatic hyperplasia (BPH) in combination with tamsulosin. Avodart, a 5-alpha reductase inhibitor, is al...